- Treatment & Clinical Trials
- In the News
- Current Research
- Archive: News ∙ Clinical Trials
Treatment & Clinical Trials
- Phase 3 Prevention Trial showed 81% reduced risk of symptomatic SARS-COV-2 infections with subcutaneous administration of REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB). University of Minnesota Medical School, Site Investigators: Dr. Anne-Marie Leuck, Dr. Mahsa Abassi, Dr. Matthew Pullen | View Press Release
- Dr. Susan Kline, Principal Investigator, is Enrolling volunteers for Phase 3 Study of NVX-CoV2373 Vaccine. Learn More
- Has someone in your household recently been diagnosed with COVID-19? Volunteer for a Clinical Trial. University of Minnesota is enrolling volunteers in a research study for individuals living with someone who recently tested positive for COVID-19. Learn More
- Dr. David Boulware's hydroxychloroquine trial on early outpatient treatment of COVID-19 has been published in the Annals of Internal Medicine. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- Dr. David Boulware discusses his Hydroxychloroquine trial on Open Forum Infectious Diseases podcast. How to Conduct a Clinical Trial During a Pandemic
In the News
- Dr. David Boulware, in the Department of Medicine, spoke with the Associated Press about ivermectin and how easy it is to experience toxic levels of the drug if taken incorrectly.
- Dr. Susan Kline and Dr. Jo-Anne Young were both honored as “Top Doctors” by Minnesota Monthly
- Dr. David Boulware was interviewed by USA Today about breakthrough COVID-19 cases after vaccination. Read here.
- Dr. David Boulware was interviewed by Reuters about U.S. regulators authorizing a third dose of COVID-19 vaccines by Pfizer and Moderna for people with compromised immune systems. See story.
- Dr. David Boulware is quoted by Salon.com in “Is there any evidence ivermectin can treat COVID-19? We analyzed the prominent scientific studies”
- Bring Me The News quote Dr. David Boulware in “Minnesota State Fair could be COVID 'super-spreader event' without mask mandate, lawmakers argue”
- “Doctors dismayed by patients who fear coronavirus vaccines, but clamor for unproven ivermectin” Dr. David Boulware interviewed with The Washington Post about ivermectin and misinformation surrounding the drug as a treatment option for COVID-19 infection.
- “U of M researchers studying how young people, immunocompromised respond to the vaccines” Dr. Susan Kline spoke with KSTP about her COVID-19 vaccine studies.
- Dr. David Boulware is mentioned in MotherJones “The Real Reason People Are Treating Themselves With Horse Dewormer”.
- Dr. Tim Schacker was interviewed by KARE 11 about the wastewater monitoring project to detect COVID-19.
- Dr. David Boulware is quoted in National Post, discussing Fluvoxamine. "Inexpensive anti-depressant could be best COVID treatment yet, Canadian-led trial finds".
- "Indiana Doctor Piles On Bogus COVID-19 Claims in Viral Video" Dr. David Boulware is mentioned in Factcheck.org article.
- "Q&A: What we know about COVID-19 delta-plus variant, boosters and the end of the surge", Dr. David Boulware is mentioned in The Mercury News.
- Dr. Susan Kline was interviewed by the Star Tribune about her clinical trial studying how effectively the COVID-19 vaccine limits spread of the coronavirus among 18- to 29-year-olds.
- Dr. David Boulware with KNX news radio, discusses medicine options still being tested, including repurposing drugs for Covid.
- Dr. Susan Kline is quoted in ABC 6 News "'We're not crying wolf here': CDC releases data, defends new mask guidance"
- Dr. Boulware was quoted in Newsweek "What is ivermectin?"
- Dr. Tim Schacker spoke with Medscape about a study – that he was not involved in – that found a reduction in HIV viral load when monkeys received immunotherapy. He explained that the study needs to be replicated in humans and that it’s likely this approach will need to be combined with others to really control HIV. "Monkeys May Lead the Way for Immunotherapy HIV Cure"
- Dr. David Boulware is mentioned in MedPage Today's article "Large ivermectin study retracted"
- Dr. David Boulware is mentioned by Epoch times: "People who recover from COVID-19 at ‘very low risk’ of re-infection: Study"
- Dr. David Boulware was quoted in MedPage Today: "Awaited Ivermectin Review Is Out — Findings are positive, but critics still want a randomized controlled trial"
- Factcheck.org mentions Dr. David Boulware's Hydroxychloroquine trial: "No New Revelation on Hydroxychloroquine and COVID-19"
- Dr. William Stauffer's study is featured in article Two U of M Medical School studies provide new evidence to battle drug price increases
- Dr. Susan Kline is mentioned in Star Tribune's article Minnesota passes 3 million vaccine recipients mark
- Dr. Susan Kline was honored as part of the Minneapolis/St. Paul Business Journal’s 2021 Health Care Heroes awards
- Dr. Tyler Bold’s Lab is conducting research on antibody prevention of reinfection in his study SERUM SARS-COV-2 NEUTRALIZATION ACTIVITY. Learn More
- A study led by Infectious Diseases Dr. Geoffrey Hart and Dr. Marco Pravetoni (Pharmacology): Understanding Protective Antibody Mechanisms in COVID-19 to Engineer Universal Coronavirus Vaccine. Learn More
- Dr. Timothy Schacker and Dr. Bradley Benson presented COVID-19: The University of Minnesota Response at the DOM Grand Rounds on April 09, 2020
- Study: COVID-19 Rapid Response Grant was received by Dr. Jose Debes and co-investigator Dr. Thomas Leventhal, for their study: Immune Signature to Evaluate COVID-19 Related Liver Injury and Outcomes
- COVID-19 Research at UMN, presented by Dr. Sarah Lofgren, at the Infection & Immunity Research Conference - March 26, 2020
Archive: News ∙ Clinical Trials
About our Division
- Talented Faculty
- Opportunities for Fellows
- Think & Act Globally
The Division of Infectious Diseases and International Medicine (IDIM) has more than 50 faculty overseeing programs in clinical care, education, and research at five teaching hospitals affiliated with the University of Minnesota Medical School: University of Minnesota Medical Center (UMMC), Minneapolis VA Health Care System, Hennepin County Medical Center, Regions Hospital, and Abbott Northwestern Hospital.
Each of these institutions serves somewhat different patient populations, and the clinical and research programs at these sites together with opportunities in global health, provide a remarkable breadth of expertise and academic experiences for trainees in the IDIM Division.
Research & Collaboration
In addition to our clinical scholars and physician scientists with clinical responsibilities, five full-time research faculty contribute importantly to the research mission of our division. The Center for Infectious Diseases and Microbiology Translational Research, an interdisciplinary research center, is the base of operation for these faculty members. Epidemiological research is carried out with colleagues in the School of Public Health, which helps administrate the division’s NIH-funded MPH/MSc-related training program. The Division also benefits from collaborations with faculty members who hold joint academic appointments in other departments, colleagues in the Center for Infectious Diseases Research and Policy, the College of Veterinary Medicine, the Minnesota Department of Health, and a number of community-based Infectious Diseases faculty.
Opportunities for Fellows
Opportunities for Fellows
During their research training, Infectious Diseases Fellows can enter an NIH-supported epidemiology (MPH)/clinical research (MSc) pathway coordinated by the School of Public Health, or they can select a laboratory-based research project at several training sites, including the Center for Translational Research in Microbiology and Infectious Diseases.
Think & Act Globally
Think & Act Globally
Because of a large influx of immigrants to Minnesota and increasing challenges from emerging infections here and abroad, especially in developing countries, our goal is to: "Think and act locally and globally."
About this Conference
The ID Intercity Clinical Case Conference is a regularly scheduled didactic session, sponsored by the Infectious Diseases Division in the Department of Medicine. Presenters are invited from the University of Minnesota, the Minnesota Department of Health and the ID community.
Held weekly on Tuesday mornings throughout the year (with the exception of July), case presentations are interactive and frequently presented as “unknowns,” encouraging discovery and participation with the audience in diagnosis and treatment remedies. Fellows, residents, students, faculty and members of the ID community all present and participate. This series is open to the public and sessions are streamed live and often recorded.
Dr. Jo-Anne Young is the conference director and Betsy Wehrwein is the organizer. For further information, please contact email@example.com.